Antidotes: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
{| width="374" border="1"
{| class="wikitable"
|-
|-
|  
|  
TOXIN  
TOXIN  


| ANTIDOTE<br>
| ANTIDOTE
|-
|-
| [[Acetaminophen (Tylenol)|Acetaminophen]]<br>
| [[Acetaminophen (Tylenol)|Acetaminophen]]  
|  
|  
N-acetylcysteine  
N-acetylcysteine  
Line 13: Line 13:


|-
|-
| Antidepressants (TCA)<br>
| Antidepressants (TCA)
|  
|  
Bicarbonate  
Bicarbonate  
Line 20: Line 20:


|-
|-
| Arsenic<br>
| Arsenic  
| Dimercaprol (BAL)<br>
| Dimercaprol (BAL)
|-
|-
| Benzodiazepines  
| Benzodiazepines  
Line 32: Line 32:


|-
|-
| [[Beta-Blocker Toxicity|Beta blockers]]<br>
| [[Beta-Blocker Toxicity|Beta blockers]]
|  
|  
Glucagon  
Glucagon  
Line 63: Line 63:


|-
|-
| [[Cyanide]]<br>
| [[Cyanide]]  
|  
|  
Kit- Hydroxycobalamin, Sodium nitrite, Sodium thiosulfate  
Kit- Hydroxycobalamin, Sodium nitrite, Sodium thiosulfate  


|-
|-
| [[Digoxin Toxicity|Digoxin]]<br>
| [[Digoxin Toxicity|Digoxin]]
| [[Dig Immune Fab]]<br>
| [[Dig Immune Fab]]
|-
|-
| [[Ethylene Glycol Poisoning|Ethylene glycol]]<br>
| [[Ethylene Glycol Poisoning|Ethylene glycol]]
|  
|  
Fomepizole  
Fomepizole  
Line 81: Line 81:
| Calcium Gluconate
| Calcium Gluconate
|-
|-
| [[Heparin (Unfractionated)|Heparin]]<br>
| [[Heparin (Unfractionated)|Heparin]]  
|  
|  
Protamine  
Protamine  


Adult: 25-50mg IV (empiric dose)  
Adult: 25-50mg IV (empiric dose) over 10 minutes


Peds: 0.6mg/kg IV (empiric dose)  
Peds: 0.6mg/kg IV (empiric dose)  


''rapid protamine infusion causes hypotension''<ref>Hirsh J. et al. "Parenteral anticoagulants: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2008; 133</ref>
|-
|-
| [[Iron (Fe)|Iron]]<br>
| [[Iron (Fe)|Iron]]  
| Deferoxamine<br>
| Deferoxamine
|-
|-
| Isoniazid (INH)<br>
| Isoniazid (INH)  
|  
|  
Pyridoxine (Vit B6)
Pyridoxine (Vit B6)
Line 102: Line 103:


|-
|-
| Lead<br>
| Lead  
| EDTA, succimer<br>
| EDTA, succimer
|-
|-
| Mercury<br>
| Mercury
| Dimercaprol (BAL)<br>
| Dimercaprol (BAL)
|-
|-
| Methanol<br>
| Methanol  
| Fomepizole<br>15mi/kg IV; then 10mg/kg q12h<br>
| Fomepizole  
15mi/kg IV; then 10mg/kg q12h<br>
|-
|-
| Methemoglobin<br>
| Methemoglobin
| Methylene blue<br>
| Methylene blue  
|-
|-
| [[Opiod Overdose|Opiods]]<br>
| [[Opiod Overdose|Opiods]]
| Nalaxone<br>
| Nalaxone  
|-
|-
| [[Organophosphates]]<br>
| [[Organophosphates]]  
| Atropine+pralidoxime<br>
| Atropine+pralidoxime
|-
|-
| Sulfonylurea  
| Sulfonylurea  
Line 129: Line 131:


|-
|-
| Valproate<br>
| Valproate
| Carnitine<br>
| Carnitine  
|-
|-
| [[Warfarin (Coumadin) Reversal|Warfarin]]<br>
| [[Warfarin (Coumadin) Reversal|Warfarin]]
| Vit K, FFP<br>
| Vit K, FFP  
|}
|}



Revision as of 00:11, 10 April 2014

TOXIN

ANTIDOTE
Acetaminophen

N-acetylcysteine

150mg/kg IV load over 60min; followed by 50mg/kg IV over 4hr and then 100mg/kg IV over 16hr 

Antidepressants (TCA)

Bicarbonate

1-2mEq/kg IV bolus followed by 2mEq/kg/hr IV infusion

Arsenic Dimercaprol (BAL)
Benzodiazepines

Flumazenil

Adult: 0.2mg IV

Peds: 0.01mg/kg IV

Beta blockers

Glucagon

Adult: 3-10mg IV

Peds: 50-150mcg/kg IV

Ca channel blockers

Calcium chloride 10%

Adult: 10 mL IV

Peds: 0.2-0.25 mL/kg IV

Clonidine

Naloxone

Adult: 0.4-2mg IV

Peds: 0.1mg/kg IV (max 2mg)

Cyanide

Kit- Hydroxycobalamin, Sodium nitrite, Sodium thiosulfate

Digoxin Dig Immune Fab
Ethylene glycol

Fomepizole

15mi/kg IV; then 10mg/kg q12h

Fluoride Calcium Gluconate
Heparin

Protamine

Adult: 25-50mg IV (empiric dose) over 10 minutes

Peds: 0.6mg/kg IV (empiric dose)

rapid protamine infusion causes hypotension[1]

Iron Deferoxamine
Isoniazid (INH)

Pyridoxine (Vit B6)

Adult: 5gm IV

Peds: 1gm/kg regardless of age [2]

Lead EDTA, succimer
Mercury Dimercaprol (BAL)
Methanol Fomepizole

15mi/kg IV; then 10mg/kg q12h

Methemoglobin Methylene blue
Opiods Nalaxone
Organophosphates Atropine+pralidoxime
Sulfonylurea

Octreotide

Adult: 50–100mcg SC q6hr

Peds: 1mcg/kg SC q6hr

Valproate Carnitine
Warfarin Vit K, FFP

Source

<references>

  1. Hirsh J. et al. "Parenteral anticoagulants: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2008; 133
  2. Minns, A. et al. Isoniazid-Induced Status Epilepticus in a Pediatric Patient After Inadequate Pyridoxine Therapy. Pediatric Emergency Care. 2010:26(5)380-381